Erste Asset Management GmbH Purchases 68,000 Shares of Masimo Corporation $MASI

Erste Asset Management GmbH raised its position in Masimo Corporation (NASDAQ:MASI) by 73.9% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 160,000 shares of the medical equipment provider’s stock after purchasing an additional 68,000 shares during the quarter. Erste Asset Management GmbH owned 0.30% of Masimo worth $22,870,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in MASI. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in Masimo by 0.6% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 11,371 shares of the medical equipment provider’s stock worth $1,894,000 after buying an additional 66 shares during the period. Assetmark Inc. raised its stake in shares of Masimo by 5.0% during the second quarter. Assetmark Inc. now owns 1,539 shares of the medical equipment provider’s stock valued at $259,000 after acquiring an additional 73 shares during the last quarter. Clearstead Advisors LLC lifted its holdings in shares of Masimo by 18.4% during the third quarter. Clearstead Advisors LLC now owns 470 shares of the medical equipment provider’s stock worth $69,000 after purchasing an additional 73 shares during the period. ProShare Advisors LLC grew its stake in shares of Masimo by 5.3% in the second quarter. ProShare Advisors LLC now owns 1,995 shares of the medical equipment provider’s stock worth $336,000 after purchasing an additional 101 shares during the last quarter. Finally, Orion Porfolio Solutions LLC increased its holdings in Masimo by 2.2% in the second quarter. Orion Porfolio Solutions LLC now owns 4,871 shares of the medical equipment provider’s stock valued at $819,000 after purchasing an additional 104 shares during the period. Institutional investors and hedge funds own 85.96% of the company’s stock.

Analysts Set New Price Targets

Several research analysts have commented on MASI shares. Piper Sandler downgraded Masimo from an “overweight” rating to a “hold” rating and set a $180.00 target price on the stock. in a report on Tuesday, February 17th. Bank of America started coverage on Masimo in a report on Monday, November 17th. They issued a “neutral” rating and a $162.00 target price on the stock. Weiss Ratings reissued a “sell (d)” rating on shares of Masimo in a research report on Thursday, January 22nd. BTIG Research downgraded shares of Masimo from a “buy” rating to a “neutral” rating in a research report on Wednesday, February 18th. Finally, Wells Fargo & Company lowered shares of Masimo from an “overweight” rating to an “equal weight” rating and reduced their price objective for the company from $190.00 to $180.00 in a research note on Wednesday, February 18th. One analyst has rated the stock with a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $181.17.

Masimo Price Performance

Masimo stock opened at $175.22 on Friday. The stock’s 50 day moving average price is $142.27 and its two-hundred day moving average price is $143.87. The stock has a market capitalization of $9.41 billion, a price-to-earnings ratio of -16.62, a PEG ratio of 1.77 and a beta of 1.26. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.92 and a current ratio of 2.84. Masimo Corporation has a 52-week low of $125.94 and a 52-week high of $194.88.

About Masimo

Masimo (NASDAQ: MASI) is a global medical technology company specializing in noninvasive monitoring solutions. The company’s flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo’s portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.